Recursion Pharmaceuticals, Inc. (RXRX)

3.43 -0.29 (-7.80%) USD  |  NASDAQ  |  Feb 20, 16:00
3.44 +0.01 (+0.29%) After-Hours: 18:50
More

Recursion Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
Pfizer Inc. Upgrade
XOMA Royalty Corp. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade